Inhibition of pulmonary metastasis in a human MT3 breast cancer xenograft model by dual liposomes preventing intravasal fibrin clot formation
Authors:
- 23 June 2009
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 121 (1) , 13-22
Abstract
The process of metastasis formation in cancer is not completely understood and is the main reason cancer therapies fail. Previously, we showed that dual liposomes simultaneously containing the hemostatic inhibitor, dipyridamole and the anticancer drug, perifosine potently inhibited metastasis, causing a 90% reduction in the number of lung metastases in a murine experimental metastasis model. To gain deeper insight into the mechanisms leading to the inhibition of metastasis by these dual liposomes, in the present study, the development of metastases by MT3 breast cancer cells in a mouse xenograft model was analyzed in more detail with regard to tumor cell settlement and metastatic growth. We found that the development of lung metastases by MT3 tumor cells is essentially dependent on the formation of fibrin clots as a precondition for the pulmonary arrest of tumor cells and the subsequent intravascular expansion of micrometastases before their invasion into the surrounding tissue.Keywords
This publication has 30 references indexed in Scilit:
- Inhibition of breast cancer metastasis by dual liposomes to disturb complex formationInternational Journal of Pharmaceutics, 2009
- Imagable 4T1 model for the study of late stage breast cancerBMC Cancer, 2008
- New treatment approaches in metastatic renal cell carcinomaCurrent Opinion in Urology, 2006
- From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapiesBreast Cancer Research and Treatment, 2005
- Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell–mediated elimination of tumor cellsBlood, 2005
- Modeling metastasis in vivoCarcinogenesis, 2004
- Mechanisms of tumour invasion and metastasis: emerging targets for therapyExpert Opinion on Therapeutic Targets, 2002
- Platelets and cancer metastasis: A causal relationship?Cancer and Metastasis Reviews, 1992
- Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable forin vivo testing of ether lipids and their derivativesBreast Cancer Research and Treatment, 1992
- The electronic aggregometer: A novel device for assessing platelet behavior in bloodJournal of Pharmacological Methods, 1980